ThaiPR.NET https://www.thaipr.net/location/east-rutherford-n-j Press Release Distribution Center of Thailand Fri, 17 Apr 2026 17:23:52 +0700 hourly 1 https://wordpress.org/?v=6.1.1 <![CDATA[Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development]]> https://www.thaipr.net/en/health_en/3400603 Wed, 25 Oct 2023 16:48:48 +0700 health_en https://www.thaipr.net/en/health_en/3400603 Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that Snapdragon Chemistry has been selected as the winner of the API Development Award, presented at the CPhI Pharma Awards in Barcelona, Spain. The annual award is presented to a company that demonstrates innovation in technologies, products, processes and services for the development […]

The post Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina]]> https://www.thaipr.net/en/health_en/3390975 Tue, 03 Oct 2023 08:25:44 +0700 health_en https://www.thaipr.net/en/health_en/3390975 Cambrex today announced the completion of its $38 million capacity expansion at its small molecule active pharmaceutical ingredient (API) manufacturing facility in High Point, North Carolina. This expansion doubles the facility’s manufacturing capacity, with new state-of-the-art analytical and chemical development laboratories, two new clinical manufacturing suites, and a small-scale commercial manufacturing operation with three work […]

The post Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial Agreement]]> https://www.thaipr.net/en/health_en/3343088 Thu, 01 Jun 2023 08:55:45 +0700 health_en https://www.thaipr.net/en/health_en/3343088 Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, yesterday celebrated the grand opening of its new Q1 Scientific facility in Belgium and announced the signing of a new commercial agreement with QUALIblood, a Belgium-based contract research organization supporting pharmaceutical companies, […]

The post Cambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial Agreement appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex Completes Expansion of Snapdragon Chemistry Facility in Waltham, Massachusetts]]> https://www.thaipr.net/en/health_en/3337426 Wed, 17 May 2023 08:30:00 +0700 health_en https://www.thaipr.net/en/health_en/3337426 Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that Snapdragon Chemistry has completed the second phase of its 51,000 square foot expansion in Waltham, Massachusetts. This expansion adds an additional 12,000 square feet to Snapdragon’s active pharmaceutical ingredient […]

The post Cambrex Completes Expansion of Snapdragon Chemistry Facility in Waltham, Massachusetts appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex Opens New Stability Storage Facility in Belgium]]> https://www.thaipr.net/en/health_en/3323428 Wed, 05 Apr 2023 08:14:40 +0700 health_en https://www.thaipr.net/en/health_en/3323428 Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that their stability storage business, Q1 Scientific, has opened a new 20,000 sq ft cGMP facility in Belgium, expanding its capacity for environmentally-controlled stability storage services to the pharmaceutical, medical […]

The post Cambrex Opens New Stability Storage Facility in Belgium appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex Recognized with CDMO Leadership Awards for 9th Consecutive Year]]> https://www.thaipr.net/en/health_en/3309100 Thu, 02 Mar 2023 08:15:21 +0700 health_en https://www.thaipr.net/en/health_en/3309100 Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has been recognized with 2023 CDMO Leadership Awards in the categories of Quality, Service, Expertise, and Compatibility. Additionally, Cambrex was selected as a “Champion” in the Service category.  This marks the ninth consecutive year Cambrex has been acknowledged with an award. […]

The post Cambrex Recognized with CDMO Leadership Awards for 9th Consecutive Year appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development Services]]> https://www.thaipr.net/en/health_en/3292610 Thu, 19 Jan 2023 09:07:58 +0700 health_en https://www.thaipr.net/en/health_en/3292610 Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has completed its acquisition of Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma customers. “Today, we […]

The post Cambrex Completes Acquisition of Snapdragon Chemistry, a Leader in Continuous Flow API Development Services appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex to Acquire Snapdragon Chemistry, a Leader in Continuous Flow API Development Services]]> https://www.thaipr.net/en/it_en/3270413 Tue, 22 Nov 2022 08:00:00 +0700 it_en https://www.thaipr.net/en/it_en/3270413 Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced that it has entered into a definitive agreement to acquire Snapdragon Chemistry, a leading US-based provider of chemical process development services to a broad range of emerging and established biopharma […]

The post Cambrex to Acquire Snapdragon Chemistry, a Leader in Continuous Flow API Development Services appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex to Invest $16.5 Million in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa]]> https://www.thaipr.net/en/health_en/3257688 Fri, 28 Oct 2022 08:00:00 +0700 health_en https://www.thaipr.net/en/health_en/3257688 Cambrex today announced it is investing in a new, 21,000-square-foot research and development facility in Minneapolis, Minnesota, expanding its capacity for small molecule development and manufacturing. Strategically located near the Minneapolis–St. Paul Airport, the new facility will specialize in analytical and chemical development for pharmaceutical drug candidates and will operate as an extension of Cambrex’s […]

The post Cambrex to Invest $16.5 Million in New R&D Facility in Minneapolis, Minnesota and Expansion in Charles City, Iowa appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex Completes Large-Scale US API Expansion]]> https://www.thaipr.net/en/health_en/3180268 Mon, 18 Apr 2022 11:50:11 +0700 health_en https://www.thaipr.net/en/health_en/3180268 Cambrex announced today the completion of a $50 million expansion of its large-scale active pharmaceutical ingredient (API) manufacturing capabilities at its Charles City, Iowa facility. The startup of the new manufacturing space is the culmination of a two-year project, originally announced in 2020, to increase the capacity of Cambrex’s flagship API facility by 30%. The […]

The post Cambrex Completes Large-Scale US API Expansion appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex Expands Biopharmaceutical Services Business]]> https://www.thaipr.net/en/health_en/3162613 Wed, 02 Mar 2022 08:10:13 +0700 health_en https://www.thaipr.net/en/health_en/3162613 Cambrex, a leading global contract development and manufacturing organization (CDMO) providing drug substance, drug product, and analytical services across the entire drug lifecycle, today announced it is significantly expanding its existing biopharmaceutical testing services business. The expansion includes 11 additional cGMP laboratories at Cambrex’s Durham, NC facility and broadens its service offering for large molecule […]

The post Cambrex Expands Biopharmaceutical Services Business appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex Recognized with 2022 CMO Leadership Awards for the 8th Consecutive Year]]> https://www.thaipr.net/en/health_en/3154102 Wed, 09 Feb 2022 08:30:33 +0700 health_en https://www.thaipr.net/en/health_en/3154102 Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has been recognized by the annual CMO (Contract Manufacturing Organization) Leadership Awards in the categories of Quality and Service. This marks the eighth consecutive year Cambrex has been acknowledged with an award. “Cambrex is honored to be identified once again by […]

The post Cambrex Recognized with 2022 CMO Leadership Awards for the 8th Consecutive Year appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity]]> https://www.thaipr.net/en/health_en/3143068 Wed, 12 Jan 2022 08:05:00 +0700 health_en https://www.thaipr.net/en/health_en/3143068 Cambrex recently celebrated the 40th anniversary of its founding in 1981. Following forty years of growth and transformation into a leading global contract development and manufacturing organization (CDMO), Cambrex continues its commitment to leadership in pharmaceutical drug substance manufacturing with over $100 million of investments in progress across its global manufacturing network. “As Cambrex celebrates […]

The post Cambrex Celebrates its 40th Anniversary while Investing over $100 million in New Drug Substance Manufacturing Capacity appeared first on ThaiPR.NET.

]]> <![CDATA[Cambrex to Invest $30 Million to Expand Manufacturing Center of Excellence at High Point, NC Facility]]> https://www.thaipr.net/en/health_en/3107303 Fri, 08 Oct 2021 08:05:17 +0700 health_en https://www.thaipr.net/en/health_en/3107303 Cambrex today announced that it is expanding its manufacturing center of excellence in High Point, NC. The $30+ million investment is designed to meet the continually growing demand for small molecule development and manufacturing services. The expansion will add new chemistry laboratories, two new clinical manufacturing suites and include a small-scale commercial manufacturing operation with […]

The post Cambrex to Invest $30 Million to Expand Manufacturing Center of Excellence at High Point, NC Facility appeared first on ThaiPR.NET.

]]>